(Reuters) - The scientist has believed since 2005 that there was enough
evidence for a strong "black box" warning on Avandia about a
risk of congestive heart failure, the senators said.
In a statement titled "Senators reveal effort by the FDA to
suppress scientific dissent and downplay safety concerns"
released with their letter, they said the reviewer was
"sidelined after voicing safety concerns" about Avandia.
Read more at Reuters.com Government Filings News
evidence for a strong "black box" warning on Avandia about a
risk of congestive heart failure, the senators said.
In a statement titled "Senators reveal effort by the FDA to
suppress scientific dissent and downplay safety concerns"
released with their letter, they said the reviewer was
"sidelined after voicing safety concerns" about Avandia.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment